Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.18
+0.08 (0.99%)
Apr 25, 2025, 12:42 PM EDT - Market open
Aurinia Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 83.4 | 48.76 | 94.09 | 231.64 | 272.35 | Upgrade
|
| Short-Term Investments | 275.04 | 301.61 | 295.22 | 234.18 | 125.98 | Upgrade
|
| Cash & Short-Term Investments | 358.44 | 350.37 | 389.31 | 465.82 | 398.33 | Upgrade
|
| Cash Growth | 2.30% | -10.00% | -16.43% | 16.94% | 30.16% | Upgrade
|
| Accounts Receivable | 36.54 | 24.09 | 13.48 | 15.41 | - | Upgrade
|
| Other Receivables | 0.6 | 0.7 | 1.1 | - | - | Upgrade
|
| Receivables | 37.14 | 24.79 | 14.58 | 15.41 | - | Upgrade
|
| Inventory | 39.23 | 39.71 | 24.75 | 19.33 | 13.93 | Upgrade
|
| Prepaid Expenses | 11.22 | 9.49 | 13.58 | 11.71 | 5.76 | Upgrade
|
| Restricted Cash | 0.04 | 0.12 | 0.08 | 0.26 | - | Upgrade
|
| Other Current Assets | 0.53 | 0.33 | 0.23 | 0.8 | 1.42 | Upgrade
|
| Total Current Assets | 446.6 | 424.8 | 442.54 | 513.32 | 419.43 | Upgrade
|
| Property, Plant & Equipment | 98.87 | 116.57 | 8.56 | 9.8 | 10.28 | Upgrade
|
| Long-Term Investments | - | 0.2 | - | - | 24.38 | Upgrade
|
| Other Intangible Assets | 4.36 | 4.98 | 6.43 | 8.4 | 9.33 | Upgrade
|
| Other Long-Term Assets | 0.82 | 1.52 | 13.34 | 11.84 | 0.25 | Upgrade
|
| Total Assets | 550.65 | 548.06 | 470.86 | 543.37 | 463.66 | Upgrade
|
| Accounts Payable | 5.19 | 4.33 | 3.09 | 3.88 | 2.64 | Upgrade
|
| Accrued Expenses | 64.97 | 50.06 | 36.28 | 30.25 | 22.16 | Upgrade
|
| Current Portion of Leases | 15.07 | 15.6 | 0.94 | 1.06 | 0.79 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.63 | 0.81 | - | Upgrade
|
| Current Unearned Revenue | 11 | 4.81 | 3.15 | 0.19 | - | Upgrade
|
| Other Current Liabilities | 1.53 | 2.39 | 2.03 | 4.45 | 6.41 | Upgrade
|
| Total Current Liabilities | 97.76 | 77.19 | 46.11 | 40.65 | 32 | Upgrade
|
| Long-Term Leases | 64.3 | 82.01 | 7.15 | 7.68 | 7.62 | Upgrade
|
| Other Long-Term Liabilities | 11.11 | 10.91 | 12.17 | 15.95 | 16.3 | Upgrade
|
| Total Liabilities | 173.17 | 170.11 | 65.43 | 64.28 | 55.91 | Upgrade
|
| Common Stock | 1,188 | 1,200 | 1,185 | 1,177 | 944.33 | Upgrade
|
| Additional Paid-In Capital | 127 | 120.79 | 85.49 | 59.01 | 39.38 | Upgrade
|
| Retained Earnings | -936.57 | -942.32 | -864.3 | -756.12 | -575.16 | Upgrade
|
| Comprehensive Income & Other | -0.65 | -0.73 | -1.06 | -0.85 | -0.81 | Upgrade
|
| Shareholders' Equity | 377.48 | 377.95 | 405.44 | 479.09 | 407.75 | Upgrade
|
| Total Liabilities & Equity | 550.65 | 548.06 | 470.86 | 543.37 | 463.66 | Upgrade
|
| Total Debt | 79.37 | 97.61 | 8.09 | 8.74 | 8.41 | Upgrade
|
| Net Cash (Debt) | 279.07 | 252.76 | 381.22 | 457.08 | 389.92 | Upgrade
|
| Net Cash Growth | 10.41% | -33.70% | -16.60% | 17.22% | 27.42% | Upgrade
|
| Net Cash Per Share | 1.91 | 1.76 | 2.69 | 3.53 | 3.29 | Upgrade
|
| Filing Date Shares Outstanding | 137.34 | 144.62 | 142.58 | 141.65 | 127.45 | Upgrade
|
| Total Common Shares Outstanding | 140.88 | 143.83 | 142.27 | 141.6 | 126.73 | Upgrade
|
| Working Capital | 348.83 | 347.61 | 396.43 | 472.68 | 387.43 | Upgrade
|
| Book Value Per Share | 2.68 | 2.63 | 2.85 | 3.38 | 3.22 | Upgrade
|
| Tangible Book Value | 373.12 | 372.98 | 399.01 | 470.69 | 398.42 | Upgrade
|
| Tangible Book Value Per Share | 2.65 | 2.59 | 2.80 | 3.32 | 3.14 | Upgrade
|
| Machinery | 2.02 | 2.02 | 1.87 | 1.88 | 0.46 | Upgrade
|
| Construction In Progress | - | - | 0.26 | 0.39 | 4.47 | Upgrade
|
| Leasehold Improvements | 3.24 | 3.24 | 2.98 | 2.98 | 0.03 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.